Anglo Asian Mining Share Discussion Threads

[wanobi] 04/6/2021 09:15

tis Friday jb2, a lot will have made good gains this week :-) Cheers Wan :-)

[jbravo2] 04/6/2021 09:13

Re SWG, the action developing now lends to 2.40-2.60
They’re finally teasing shares out here just below that so one would imagine there will be decent volume in that range.
Amazing how for some people that extra 3% has made all the difference on yesterday :D

[riggerbeautz] 04/6/2021 09:04

I’m just sat watching but monitor both listings, Oz market didn’t seem to know it was coming earlier in the week or I’d guess the price would’ve dropped more. It’s interesting to me, letting the dust settle before deciding.

[jbravo2] 04/6/2021 09:02

Yeah I added 4000 this week too

[wanobi] 04/6/2021 09:00

yeah, saw that Rb,,, not invested, but watching,,, think the PM's guy is a holder, so will be interesting to hear his thoughts next time they podcast, cheers Wan :-)

[riggerbeautz] 04/6/2021 08:59

Anyone still following CCZ, know it’s been mentioned here before. See they couldn’t resist grabbing more dosh whilst the going’s good. Small discount but the board need to show their mettle now, wouldn’t hurt to put their hands in their pockets either.

[wanobi] 04/6/2021 08:58

many thanx again jb2, I added 5K shares to the ever increasing SWG share pot today :-)
Cheers
Wan :-)

[jbravo2] 04/6/2021 08:56

Yes SWG continues its climb back to where it should be. As I said it’s always likely to be smaller percentages each day than some stocks but likely to show fewer rip reversals as well.
Still think it’ll fly to 2.40-2.60 before even thinking about a consolidation. Whether it’ll happen or not isn’t for sure though naturally. It could 3.20 it

[wanobi] 04/6/2021 08:42

free stock charts from uk.advfn.com


yep :-) looking good av68, well played and many thanx for heads up here :-)

Cheers
Wan :-)

[avsome1968] 04/6/2021 08:38

Market starting to warm up to VRE my third biggest holing up 12% at the moment been vey low key for many months hopefully its starting to shine.

[wanobi] 04/6/2021 08:33

SWG no stock about :-) Cheers Wan :-)

[wanobi] 04/6/2021 08:30

yes, I'd be in for more too at 80p av68,,, cheers Wan :-)

[avsome1968] 04/6/2021 08:26

WAN

DDDD covid play was always going to be a shot in the dark, with the vaccines rolling out now and being a huge success pointless wasting anymore money on a covid play.
So after a long delay with covid nice to see the enrolment of 30 patients for Part A Phase I/II clinical trial of MRx-4DP0004 in patients with partly-controlled asthma.
If it drops to fill that gap will add a few more.

[brasso3] 04/6/2021 08:14

Gold bouncing off the trend line since the double bottom

[wanobi] 04/6/2021 08:12

maybe, but too early in the day to say for me :-) LOL,,,, oh what a game this is :-) LOL Cheers Wan :-)

[captain james t kirk] 04/6/2021 08:10

Looks like Mr Market is quite relaxed about it and is also focussed on the bigger picture, particularly with the oncology results due soon.

[zangdook] 04/6/2021 08:05

Article with a lot of unflattering stuff about Azerbaijan from an Israeli viewpoint

[wanobi] 04/6/2021 08:01

I don't have a problem with 4D focusing on its long term goals and agree, in the longer term it's the right thing to do,,, its just Mr Market I can never read,,, one suspects most will just see cv19 trial ditched/failed and run for the hills which as we see so often may give us LTH's a chance at some cheap stock :-) Cheers Wan :-)

[mr roper] 04/6/2021 07:44

I read the 4d update as good news. Both in non core areas, it was well known to anyone who had spoken to the company that the asthma trial was on hold last year due to covid and that the covid trial never really started. Either way, oncology is the core focus for the next few months. Expect volatility

[wanobi] 04/6/2021 07:30

I suspect you're correct cjtk,,, 80p should fill it :-) Cheers Wan :-)

free stock charts from uk.advfn.com

[captain james t kirk] 04/6/2021 07:26

"No idea how the market will view todays RNS!!!"
I'm sorry to say not well Wan. Where's that gap !

[wanobi] 04/6/2021 07:24

POG - IRC announced that the Russian Federal Service for Environmental, Technological, and Nuclear Supervision has initiated an administrative offence proceeding against K&S in the Obluchensky District Court of the Jewish Autonomous Region, in Russia, for operating the K&S project without the requisite approvals. The Company understands that no court date has been set and that K&S will continue to operate as usual. The potential outcome of the administrative offence proceeding is unclear. The Company understands that if K&S is found to have committed an offence a fine may be imposed by the court and/or K&S may be required to suspend its operations until the required formalities are completed and necessary approvals are received.

I'm not up to speed on this situation!

Cheers
Wan :-)

[wanobi] 04/6/2021 07:21

JLP - Jubilee, a leader in metals processing with operations in Africa (AIM: JLP/Altx: JBL), is pleased to announce a further substantial acquisition of the rights to 944 000 tonnes of PGM containing tailings in the Eastern Limb of the PGM-rich Bushveld Complex. This comes in quick succession to the PGM Supply Agreements entered in to and the acquisition of 255 000 tonnes of PGM containing material in the Western Limb, as announced on 3 June 2021.

Cheers
Wan :-)

[wanobi] 04/6/2021 07:18

4D - "The completion of enrollment in Part A of 4D pharma's asthma study is an important milestone for this program. This is expected to provide further validation of the favorable safety profile of LBPs as a novel class of drug across a wide range of indications, including respiratory disease," said Alex Stevenson, Chief Scientific Officer, 4D pharma. "For the MRx-4DP0004 program, as COVID-19 hospitalizations continue to decline with the increase in vaccinations, the voluntary discontinuation of enrollment into our COVID-19 study enables 4D pharma to focus our efforts and resources on developing our novel LBP for the treatment of asthma. We look forward to elucidating important findings regarding the potential of our oral, gut-restricted, single strain LBPs to exert potent effects on the human immune system with therapeutic effects in organs and tissues away from the gut."

The first-in-human Phase I/II trial is a two part, multi-center, randomized, double-blind, placebo-controlled trial of MRx-4DP0004 in patients taking long-term medication for asthma. Patients receive oral MRx-4DP0004 or placebo twice daily for 12 weeks.

No idea how the market will view todays RNS!!!

Cheers
Wan :-)